FDA Approval of Eteplirsen for Muscular Dystrophy
Authors:
- 11 April 2017
- journal article
- other
- Published by American Medical Association (AMA) in JAMA
- Vol. 317 (14) , 1480
Abstract
To the Editor Drs Kesselheim and Avorn raised concerns about the approval by the US Food and Drug Administration (FDA) of eteplirsen to treat Duchenne muscularKeywords
This publication has 1 reference indexed in Scilit:
- The case for eteplirsen: Paving the way for precision medicineMolecular Genetics and Metabolism, 2016